Terminated NA INTERVENTIONAL 1-arm NCT06038513

Transnasal Induction of Normothermia for Neurogenic Fever

A Prospective, Open Label Clinical Trial to Evaluate the Safety and Efficacy of the COOLSTAT® Transnasal Thermal Regulating Device in Inducing Normothermia for Neurogenic Fever in an Intensive Care Setting

Sponsor: CoolTech LLC

Conditions Metabolic Encephalopathy Seizures Stroke Hemorrhagic Stroke, Ischemic

Interventions Transnasal Thermal Regulating Device

Updated 6 times since 2023 Last updated: Jan 23, 2026 Started: Nov 21, 2023 Primary completion: Aug 1, 2025 Completion: Nov 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient accrual

Other terminated trials from CoolTech LLC

Episodic Migraine · Phase NA · Sep 2022

More terminations from CoolTech LLC

Listed as NCT06038513, this NA trial focuses on Metabolic Encephalopathy and Seizures and remains terminated or withdrawn. Sponsored by CoolTech LLC, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Terminated NA

Status: Recruiting → Terminated
Mar 2025 — Feb 2026 [monthly]

Recruiting NA
Sep 2024 — Mar 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Oct 2023 — Jan 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CoolTech LLC
Maryland Industrial Partnerships

Data source: CoolTech LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States